Abstract |
Flavone-8-acetic acid plus recombinant human interleukin 2 is a successful antitumor therapy in mice bearing the Renca murine renal cell carcinoma. This report demonstrates that T cells, particularly CD8+ T cells, are critical for the generation of this response. Initial experiments examining T-cell signal transduction proteins demonstrated that T cells from Renca-bearing mice had undetectable levels of p56lck and zeta-chain of the T-cell receptor and that flavone-8-acetic acid and recombinant human interleukin 2 therapy could be used as a model for reversal of these alterations. However, further experimentation showed that the majority of the reduction in zeta-chain and part of the reduction in p56lck was due to degradation of these molecules during protein extraction caused by mature granulocytes contaminating the enriched T-cell population. This was not the case for nuclear c-Rel or NF kappa B p65, which remained at undetectable/reduced levels in the absence of granulocytes, confirming our previous data that transcription factor alterations exist in tumor-bearing mice. Thus, most of the reduction in zeta-chain in T cells from Renca-bearing mice is due to granulocyte contamination and emphasizes the need to use pure T-cell populations and/or sufficient amounts and types of protease inhibitors when quantitating proteins in T cells from tumor-bearing mice.
|
Authors | J L Franco, P Ghosh, R H Wiltrout, C R Carter, A H Zea, N Momozaki, A C Ochoa, D L Longo, T J Sayers, K L Komschlies |
Journal | Cancer research
(Cancer Res)
Vol. 55
Issue 17
Pg. 3840-6
(Sep 01 1995)
ISSN: 0008-5472 [Print] United States |
PMID | 7641202
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Flavonoids
- Interleukin-2
- Receptors, Antigen, T-Cell
- flavone acetic acid
- Protein-Tyrosine Kinases
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- CD4-Positive T-Lymphocytes
(chemistry, immunology)
- CD8-Positive T-Lymphocytes
(chemistry, immunology)
- Carcinoma, Renal Cell
(immunology, therapy)
- Flavonoids
(therapeutic use)
- Granulocytes
(immunology)
- Immunotherapy
- Interleukin-2
(therapeutic use)
- Kidney Neoplasms
(immunology, therapy)
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
- Mice
- Mice, Inbred BALB C
- Protein-Tyrosine Kinases
(analysis)
- Receptors, Antigen, T-Cell
(analysis)
- Signal Transduction
(physiology)
|